查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826795

2025年植入式心臟整流去顫器（ICD）全球市場報告

Implantable Cardioverter Defibrillators (ICDs) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，植入式心臟整流去顫器(ICD) 市場規模強勁成長，從 2024 年的 37.6 億美元增至 2025 年的 39.8 億美元，複合年成長率為 5.8%。這段歷史時期的成長可歸因於心臟麻痹率的上升、植入式心臟整流去顫器在心臟麻痹二級預防中的應用、公眾意識的增強、人口老齡化、政府和醫療機構的支持性政策以及醫療保健可及性的提高。

植入式心臟整流去顫器(ICD) 市場預計將在未來幾年強勁成長，到 2029 年將達到 49.5 億美元，複合年成長率為 5.6%。預測期內的成長歸因於植入式心臟整流去顫器的接受度不斷提高、對更個人化的心臟護理的需求不斷成長、心律不整盛行率的上升以及新興市場的需求不斷成長。預測期內的主要趨勢包括技術進步、無需經靜脈導線的皮下 ICD 的引入、對具有心律調節器功能的組合式 ICD 設備的需求、增強的感測和檢測演算法、無線充電和電池技術的持續進步以及人工智慧 (AI) 在醫療保健和數據分析中的整合。

植入式心臟整流去顫器(ICD) 是一種小型裝置，通常放置在靠近胸部的皮膚下。它用於監測心律，並在檢測到危及生命的心律不整（例如室顫）時發出電擊。 ICD 的主要目的是透過恢復正常心律來預防心臟麻痹。

ICD 有多種類型，包括單腔 ICD、雙腔 ICD 和雙心室 ICD。單腔 ICD 植入於胸腔，用於偵測並矯正某個心腔內的異常心律。這類裝置用途廣泛，包括治療心搏過緩、心搏過速和心臟衰竭，並在醫院、專科診所和門診手術中心等各種場所使用。

2025 年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療保健提供者正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品成本的上漲，其中許多產品的國內替代品有限。這些不斷上漲的成本使醫療保健預算捉襟見肘，導致一些醫療機構推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，造成供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供植入式心臟整流去顫器( ICD) 市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率，以及詳細的植入式心臟整流去顫器(ICD) 細分市場、市場趨勢和商業機會。本植入式心臟整流去顫器( ICD) 市場研究報告對該行業的現狀和未來走勢進行了詳細分析，為您提供所需的一切觀點。

未來五年5.6%的成長率預測比我們先前的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。關稅上漲可能會增加美國醫院的負擔，使其從愛爾蘭和墨西哥進口的ICD組件和導線系統的成本增加，加劇心臟護理延誤，並增加電生理實驗室的成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，其影響也將更加廣泛。

心血管疾病 (CVD) 的盛行率不斷上升，預計將在未來幾年推動植入式心臟整流去顫器(ICD) 市場的擴張。 CVD 是指影響心臟和血管的多種疾病，包括心臟病發作、中風和高血壓。這些疾病通常與不良飲食、久坐不動的生活方式、吸煙和遺傳易感性等因素有關。心血管疾病的增加主要是由於人口老化、不健康的生活方式以及肥胖、糖尿病和高血壓等風險因素的增加。 ICD 在心血管疾病管理中發揮關鍵作用，它可以透過向有心臟麻痹風險的患者提供挽救生命的電擊並恢復正常心律。例如，2023年12月，澳洲健康與福利研究所報告稱，醫生認證的因心臟疾病（CHD）導致的死亡人數有所增加，從2021年的14,100人增加到2022年的14,900人。因此，心血管疾病盛行率的上升正在推動ICD市場的成長。

植入式心臟整流去顫器(ICD) 市場的主要企業正專注於低電流去心房顫動等技術創新，以提高設備性能、延長電池壽命並增強患者舒適度。這些去心房顫動旨在以最小的功耗向心臟發送電擊，從而延長電池壽命並確保有效治療心律不整。例如，2023 年 10 月，法國醫療設備製造商微創 CRM 在日本推出了 ULYS植入式心臟整流去顫器(ICD) 和 INVICTA去心房顫動顫導線，標誌著心臟治療技術的重要里程碑。這些設備具有先進的功能，例如低電流消耗以延長電池壽命和 MRI 相容性，適用於需要診斷成像的患者。 ULYS ICD 還具有 PARAD+ 心律不整辨識演算法和 AutoMRI 功能，可提高 MRI 掃描期間的患者安全性。此外，INVICTA導線在臨床試驗中表現出100%的植入成功率和97.4%的無併發症率，證明了其高度的可靠性和有效性。

2023年6月，總部位於荷蘭的醫療科技公司荷蘭皇家飛利浦與百多力公司（BIOTRONIK）合作，擴大飛利浦Symphony Suite心血管設備系列。 PhilipsSymphony Suite是一款領先的心血管門診實驗室（OBL）和門診手術中心（ASC）解決方案。透過此次合作，飛利浦Symphony Suite將與百多力公司全面的心律管理和介入心臟病學產品相整合，從而改善個人化患者照護方案，並支持向院外護理的轉變。百多力公司是一家總部位於美國的醫療設備製造商，專注於提供旨在改善心血管和血管內疾病患者生活品質的產品和服務。

植入式心臟整流去顫器(ICD) 市場涵蓋治療性去心房顫動、可充電和一次性電池、編程設備、植入工具、電極和導線的銷售。該市場的價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球植入式心臟整流去顫器(ICD)：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球植入式心臟整流去顫器（ICD）市場：成長率分析
  • 全球植入式心臟整流去顫器(ICD) 市場表現：規模與成長，2019-2024 年
  • 全球植入式心臟整流去顫器(ICD) 市場預測：規模與成長，2024-2029 年，2034 年
  • 全球植入式心臟整流去顫器（ICD）：總目標市場（TAM）

第6章 市場細分

  • 全球植入式心臟整流去顫器(ICD) 市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 單腔植入式心臟整流去顫器（ICD）
  • 植入式心臟整流去顫器（ICD）
  • 雙心室裝置
  • 全球植入式心臟整流去顫器(ICD) 市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 心搏過緩
  • 心搏過速
  • 心臟衰竭
  • 其他用途
  • 全球植入式心臟整流去顫器(ICD) 市場：依最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他最終用戶
  • 全球植入式心臟整流去顫器(ICD) 市場：按類型細分（單植入式心臟整流去顫器(ICD)）、業績及預測，2019-2024 年、2024-2029 年、2034 年
  • 標準單腔ICD
  • MRI相容單腔ICD
  • 無線單腔ICD
  • 全球植入式心臟整流去顫器(ICD) 市場：按雙腔植入式心臟整流去顫器細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 標準雙腔ICD
  • MRI相容雙腔ICD
  • 無線雙腔ICD
  • 全球植入式心臟整流去顫器(ICD) 市場：按雙心室裝置細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • CRT-D（心臟再同步治療去心房顫動）
  • CRT-P（心臟再同步治療心律調節器）
  • 具有先進功能（遠端監控、無線功能）的雙心室 ICD

第7章 區域和國家分析

  • 全球植入式心臟整流去顫器(ICD) 市場：區域分析、預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球植入式心臟整流去顫器(ICD) 市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 植入式心臟整流去顫器(ICD) 市場：競爭格局
  • 植入式心臟整流去顫器(ICD) 市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • ZOLL Medical Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • St. Jude Medical Inc.
  • BIOTRONIK SE & Co. KG
  • Nihon Kohden Corporation
  • Fukuda Denshi Co. Ltd.
  • LivaNova PLC
  • MicroPort Scientific Corporation
  • Japan Lifeline Co. Ltd.
  • AtriCure Inc.
  • Physio-Control Inc.
  • BPL Medical Technologies Private Limited
  • Kestra Medical Technologies Inc.
  • CU Medical Germany GmbH
  • Metrax GmbH
  • Intermedics Inc.
  • Sorin Group SpA

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年植入式心臟整流去顫器（ICD）市場：提供新機會的國家
  • 2029年植入式心臟整流去顫器（ICD）市場：細分市場帶來新機會
  • 植入式心臟整流去顫器(ICD) 市場 2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r33769u

Implantable cardioverter defibrillators (ICDs) are compact devices placed beneath the skin, usually near the chest area. They are designed to monitor the heart's rhythm and administer electrical shocks when a life-threatening arrhythmia, such as ventricular fibrillation, is identified. The primary goal of ICDs is to prevent sudden cardiac arrest by restoring a normal heart rhythm.

There are several types of implantable cardioverter defibrillators (ICDs), including single-chamber ICDs, dual-chamber ICDs, and biventricular devices. A single-chamber ICD is implanted in the chest and is responsible for detecting and correcting abnormal heart rhythms in one of the heart's chambers. This device serves various purposes, such as managing bradycardia, tachycardia, and heart failure, and is utilized in different settings, including hospitals, specialty clinics, ambulatory surgical centers, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The implantable cardioverter defibrillators (ICDs) market research report is one of a series of new reports from The Business Research Company that provides implantable cardioverter defibrillators (ICDs) market statistics, including the implantable cardioverter defibrillators (ICDs) industry global market size, regional shares, competitors with the implantable cardioverter defibrillators (ICDs) market share, detailed implantable cardioverter defibrillators (ICDs) market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable cardioverter defibrillators (ICDs) industry. This implantable cardioverter defibrillators (ICDs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable cardioverter defibrillators (icds) market size has grown strongly in recent years. It will grow from $3.76 billion in 2024 to $3.98 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing incidence of sudden cardiac arrest, inclusion of implantable cardioverter defibrillator in secondary prevention of sudden cardiac arrest, growing public awareness, rise in the aging population, supportive policies by governments and healthcare organizations, increased healthcare access.

The implantable cardioverter defibrillators (icds) market size is expected to see strong growth in the next few years. It will grow to $4.95 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to growing acceptance of implantable defibrillators, rise in demand for more personalized cardiac care, rising prevalence of cardiac rhythm disorders, rising demand in emerging markets. Major trends in the forecast period include technological advancements, introduction of subcutaneous ICD that avoid transvenous leads, demand for combination ICD devices with pacemaker functionality, enhancing sensing and detection algorithms, continuous advancements in wireless charging and battery technology, integration of artificial intelligence (AI) in healthcare and data analytics.

The forecast of 5.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. hospitals by driving up the cost of ICD components and lead systems sourced from Ireland and Mexico, exacerbating cardiac care delays and increasing electrophysiology lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of cardiovascular diseases (CVDs) is expected to drive the expansion of the implantable cardioverter defibrillators (ICDs) market in the coming years. CVDs are a range of disorders that impact the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension. These diseases are often linked to factors such as poor diet, sedentary lifestyle, smoking, and genetic predisposition. The rise in cardiovascular diseases is mainly attributed to aging populations, unhealthy lifestyle habits, and increasing rates of risk factors such as obesity, diabetes, and hypertension. ICDs play a critical role in managing CVDs by delivering life-saving electrical shocks to restore normal heart rhythms in individuals at risk of sudden cardiac arrest. For example, in December 2023, the Australian Institute of Health and Welfare reported a rise in doctor-certified deaths due to coronary heart disease (CHD), which increased from 14,100 in 2021 to 14,900 in 2022. Therefore, the increasing prevalence of cardiovascular diseases is fueling the growth of the ICD market.

Leading companies in the implantable cardioverter defibrillators (ICDs) market are concentrating on technological innovations, such as low current consumption defibrillators, to improve device performance, extend battery life, and enhance patient comfort. These defibrillators are designed to administer electrical shocks to the heart while using less energy, thereby increasing battery longevity and ensuring effective treatment of arrhythmias. For example, in October 2023, MicroPort CRM, a medical device company based in France, introduced the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan, marking a significant milestone in cardiac care technology. These devices incorporate advanced features such as low current consumption to extend battery life and MRI compatibility for patients requiring imaging procedures. The ULYS ICD also includes the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, improving patient safety during MRI scans. Moreover, the INVICTA lead demonstrated a 100% implantation success rate and a 97.4% complication-free rate in clinical trials, showcasing its high reliability and effectiveness.

In June 2023, Royal Philips, a health technology company based in the Netherlands, joined forces with Biotronik to broaden the range of cardiovascular devices available to users of Philips SymphonySuite, a leading solution designed for cardiovascular office-based labs (OBLs) and ambulatory surgery centers (ASCs). The collaboration integrates Philips SymphonySuite with Biotronik's comprehensive selection of cardiac rhythm management and cardiovascular intervention products, thereby improving options for personalized patient care and supporting the shift towards out-of-hospital care settings. Biotronik, a US-based medical device company, specializes in providing products and services that aim to enhance the quality of life for patients with cardiovascular and endovascular conditions.

Major players in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., and Sorin Group S.p.A.

North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in implantable cardioverter defibrillators (ICDs) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the implantable cardioverter defibrillators (ICDs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable cardioverter defibrillators (ICDs) market consists of sales of therapy defibrillators, rechargeable and non-rechargeable batteries, programming devices, implantation tools, electrodes, and leads. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardioverter Defibrillators (ICDs) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardioverter defibrillators (icds) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardioverter defibrillators (icds) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable cardioverter defibrillators (icds) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs); Dual Chamber Implantable Cardioverter Defibrillators (ICDs); Biventricular Devices
  • 2) By Applications: Bradycardia; Tachycardia; Heart Failure; Other Applications
  • 3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs; MRI-Compatible Single Chamber ICDs; Wireless Single Chamber ICDs
  • 2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs; MRI-Compatible Dual Chamber ICDs; Wireless Dual Chamber ICDs
  • 3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator); CRT-P (Cardiac Resynchronization Therapy Pacemaker); Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
  • Companies Mentioned: Abbott Laboratories; Medtronic Inc.; Koninklijke Philips N.V.; Boston Scientific Corporation; ZOLL Medical Corporation; St. Jude Medical Inc.; BIOTRONIK SE & Co. KG; Nihon Kohden Corporation; Fukuda Denshi Co. Ltd.; LivaNova PLC; MicroPort Scientific Corporation; Japan Lifeline Co. Ltd.; AtriCure Inc.; Physio-Control Inc.; BPL Medical Technologies Private Limited; Kestra Medical Technologies Inc.; CU Medical Germany GmbH; Metrax GmbH; Intermedics Inc.; Sorin Group S.p.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardioverter Defibrillators (ICDs) Market Characteristics

3. Implantable Cardioverter Defibrillators (ICDs) Market Trends And Strategies

4. Implantable Cardioverter Defibrillators (ICDs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Cardioverter Defibrillators (ICDs) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Cardioverter Defibrillators (ICDs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Cardioverter Defibrillators (ICDs) Market Growth Rate Analysis
  • 5.4. Global Implantable Cardioverter Defibrillators (ICDs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Cardioverter Defibrillators (ICDs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Cardioverter Defibrillators (ICDs) Total Addressable Market (TAM)

6. Implantable Cardioverter Defibrillators (ICDs) Market Segmentation

  • 6.1. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Chamber Implantable Cardioverter Defibrillators (ICDs)
  • Dual Chamber Implantable Cardioverter Defibrillators (ICDs)
  • Biventricular Devices
  • 6.2. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bradycardia
  • Tachycardia
  • Heart Failure
  • Other Applications
  • 6.3. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.4. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Single Chamber Implantable Cardioverter Defibrillators (ICDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Single Chamber ICDs
  • MRI-Compatible Single Chamber ICDs
  • Wireless Single Chamber ICDs
  • 6.5. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Dual Chamber Implantable Cardioverter Defibrillators (ICDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Dual Chamber ICDs
  • MRI-Compatible Dual Chamber ICDs
  • Wireless Dual Chamber ICDs
  • 6.6. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Biventricular Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CRT-D (Cardiac Resynchronization Therapy Defibrillator)
  • CRT-P (Cardiac Resynchronization Therapy Pacemaker)
  • Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)

7. Implantable Cardioverter Defibrillators (ICDs) Market Regional And Country Analysis

  • 7.1. Global Implantable Cardioverter Defibrillators (ICDs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Cardioverter Defibrillators (ICDs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market

  • 8.1. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardioverter Defibrillators (ICDs) Market

  • 9.1. China Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 9.2. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardioverter Defibrillators (ICDs) Market

  • 10.1. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardioverter Defibrillators (ICDs) Market

  • 11.1. Japan Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 11.2. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardioverter Defibrillators (ICDs) Market

  • 12.1. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market

  • 13.1. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardioverter Defibrillators (ICDs) Market

  • 14.1. South Korea Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 14.2. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market

  • 15.1. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 15.2. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardioverter Defibrillators (ICDs) Market

  • 16.1. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardioverter Defibrillators (ICDs) Market

  • 17.1. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardioverter Defibrillators (ICDs) Market

  • 18.1. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardioverter Defibrillators (ICDs) Market

  • 19.1. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardioverter Defibrillators (ICDs) Market

  • 20.1. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market

  • 21.1. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 21.2. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardioverter Defibrillators (ICDs) Market

  • 22.1. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardioverter Defibrillators (ICDs) Market

  • 23.1. North America Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 23.2. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardioverter Defibrillators (ICDs) Market

  • 24.1. USA Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 24.2. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardioverter Defibrillators (ICDs) Market

  • 25.1. Canada Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 25.2. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardioverter Defibrillators (ICDs) Market

  • 26.1. South America Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 26.2. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardioverter Defibrillators (ICDs) Market

  • 27.1. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardioverter Defibrillators (ICDs) Market

  • 28.1. Middle East Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 28.2. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardioverter Defibrillators (ICDs) Market

  • 29.1. Africa Implantable Cardioverter Defibrillators (ICDs) Market Overview
  • 29.2. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardioverter Defibrillators (ICDs) Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Cardioverter Defibrillators (ICDs) Market Competitive Landscape
  • 30.2. Implantable Cardioverter Defibrillators (ICDs) Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. ZOLL Medical Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardioverter Defibrillators (ICDs) Market Other Major And Innovative Companies

  • 31.1. St. Jude Medical Inc.
  • 31.2. BIOTRONIK SE & Co. KG
  • 31.3. Nihon Kohden Corporation
  • 31.4. Fukuda Denshi Co. Ltd.
  • 31.5. LivaNova PLC
  • 31.6. MicroPort Scientific Corporation
  • 31.7. Japan Lifeline Co. Ltd.
  • 31.8. AtriCure Inc.
  • 31.9. Physio-Control Inc.
  • 31.10. BPL Medical Technologies Private Limited
  • 31.11. Kestra Medical Technologies Inc.
  • 31.12. CU Medical Germany GmbH
  • 31.13. Metrax GmbH
  • 31.14. Intermedics Inc.
  • 31.15. Sorin Group S.p.A.

32. Global Implantable Cardioverter Defibrillators (ICDs) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardioverter Defibrillators (ICDs) Market

34. Recent Developments In The Implantable Cardioverter Defibrillators (ICDs) Market

35. Implantable Cardioverter Defibrillators (ICDs) Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer